AG
CRDF icon

Advisor Group’s Cardiff Oncology CRDF Stock Holding History

Advisor Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20
Closed – – 5244
2019
Q1 		$0 Hold
20
– – ﹤0.01% 5227
2018
Q4 		$0 Hold
20
– – ﹤0.01% 5119
2018
Q3 		$0 Sell
20
-23
-53% -$109 ﹤0.01% 5118
2018
Q2 		$0 Buy
43
+1
+2% +$17 ﹤0.01% 4940
2018
Q1 		$1K Hold
42
– – ﹤0.01% 4798
2017
Q4 		$1K Sell
42
-624
-94% -$27.6K ﹤0.01% 4794
2017
Q3 		$35K Buy
666
+84
+14% +$5.24K ﹤0.01% 3192
2017
Q2 		$53K Sell
582
-55
-9% -$3.54K ﹤0.01% 2805
2017
Q1 		$53K Sell
637
-48
-7% -$6.52K ﹤0.01% 2654
2016
Q4 		$103K Sell
685
-828
-55% -$193K ﹤0.01% 2044
2016
Q3 		$489K Sell
1,513
-83
-5% -$30.3K 0.01% 990
2016
Q2 		$520K Buy
+1,596
New +$550K 0.01% 902

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisor Group's CRDF Position: Q2 2019 in Review

Advisor Group sold out of Cardiff Oncology (CRDF) in Q2 2019, closing a stake of 20 shares.

Advisor Group first reported a position in CRDF in Q2 2016 and held it in 12 quarters. The position peaked at $520K in Q2 2016. 23 funds tracked by Wall St. Rank hold CRDF as of Q2 2019.

  • Advisor Group reported no remaining Cardiff Oncology position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 20 Cardiff Oncology shares in Q2 2019.
  • Advisor Group first reported a position in Cardiff Oncology in Q2 2016 and held it in 12 quarters.
  • Advisor Group's Cardiff Oncology position peaked at $520K in Q2 2016.
  • 23 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.